Decipher Genomic Classifier Measured on Prostate Biopsy Predicts Metastasis Risk

Urology- United States

doi 10.1016/j.urology.2016.01.012

Full Text

Abstract

Available in

Categories

Urology

Date

Authors

Publisher

Elsevier BV

Related search

Evaluation of the Decipher Prostate Cancer Classifier to Predict Metastasis and Disease-Specific Mortality From Genomic Analysis of Diagnostic Prostate Needle Biopsy Specimens.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2017English

Utilization of Biopsy-Based Genomic Classifier to Predict Distant Metastasis After Definitive Radiation and Short-Course ADT for Intermediate and High-Risk Prostate Cancer

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2017English

Evaluation of a Genomic Classifier in Radical Prostatectomy Patients With Lymph Node Metastasis

Research and Reports in Urology
Urology
2016English

Genomic Classifier for Guiding Treatment of Intermediate-Risk Prostate Cancers to Dose-Escalated Image-Guided Radiotherapy Without Hormone Therapy

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

Risk Factors Affecting Complications Due to Prostate Biopsy

The Bulletin of Urooncology
2019English

A Random Forest Classifier Predicts Recurrence Risk in Patients With Ovarian Cancer

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

Identification of Prostate Cancer Metastasis-Suppressor Genes Using Genomic shRNA Libraries

2008English

Is a Negative Prostate Biopsy a Risk Factor for a Prostate Cancer Related Death?

The Lancet Oncology
Oncology
2017English

MRI Assisted Stereotactic Biopsy (MAST) in Patients With Elevated Prostate Cancer Risk and Previous Negative Biopsy

JOJ Urology & Nephrology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy